Xenetic Biosciences, Inc. Appoints Greg Macmichael, Ph.D. to Scientific Advisory Board
February 27, 2020 at 01:04 pm EST
Xenetic Biosciences, Inc. appointed Greg MacMichael, Ph.D. to its Scientific Advisory Board. Since 2010, Greg MacMichael, Ph.D., has served as the President and Founder of CMC BioServices, LLC. Dr. MacMichael most recently served as the Senior Vice President of Technical Operations at Axovant Gene Therapies where he oversaw the manufacturing of Axovant's pipeline of gene therapies.